MedPath

VINCRISTINE SULFATE INJECTION

VINCRISTINE SULFATE INJECTION

Approved
DIN Number

02143305

Drug Class

Human

Market Date

Dec 31, 1995

Company
HC

teva canada limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02143305
AIG Number0107646001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01CA02 VINCRISTINE
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

VINCRISTINE SULFATEActive
Strength: 1 MG / ML
Monograph: VINCRISTINE SULFATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.